Cleveland Clinic launches new RPM and tele-ICU initiative with Masimo

2024-07-03
Cleveland Clinic is working with Masimo on a new partnership focused on hospital-based remote patient monitoring and virtual critical care. WHY IT MATTERS The work will include the integration of Cleveland Clinic's critical care and non-critical care central patient monitoring platforms with Masimo's Hospital Automation platform, according to the company, in an effort to provide tools for clinicians that offer "enhanced situational awareness and clinical decision support for hospitalized patients, including the critically ill." The health system will also work with the vendor on initiatives around predictive analytics and other AI-based algorithms, with a special focus on cardiology, they say. Cleveland Clinic already has a critical care and non-critical care central monitoring platform that enables continuous monitoring of vital signs for both intensive care and non-ICU patients, with RPM programs serving 11 hospitals and providing intensivist monitoring, 24/7 critical care nursing and patient management. Masimo's Hospital Automation platform, meanwhile, is built around tools designed to help clinicians boost care not just at the bedside, but wherever the patient may be in the care continuum. Those technologies include monitoring and wearable sensors, high-fidelity medical device integration, applications for surveillance and data visualization, and other AI-enabled technologies to help clinicians triage patients and spot changes in their conditions faster and more efficiently. They're powered by the company's Halo engine, "which identifies deterioration patterns in multiple physiological parameters simultaneously," Masimo says. Cleveland Clinic will work with the developer to jointly develop other Halo-based decision-support tools to support clinicians with earlier detection of adverse events in patients of varying acuities. With Masimo, the health system also aims to bring its innovations and patient benefits "to other healthcare systems in the future," the company said in a news release. THE LARGER TREND As more and more major health systems either launch or refine their existing RPM, tele-ICU and hospital-at-home initiatives, many of them are seeing the programs pay big dividends – for patient care , provider experience and the bottom line . But these care modalities are not without their risks , and success with virtual and remote care depends on thoughtful implementations . ON THE RECORD "We look forward to exploring the effects of next-gen inpatient wearables, and as the capabilities of AI continue to advance, studying the potential impact on the care of cardiac patients, including those undergoing cardiac surgery," said Dr. Thomas Callahan, staff cardiologist at Cleveland Clinic's Heart, Vascular & Thoracic Institute and principal investigator for the AI study, in a statement. "By harnessing Masimo's AI-powered decision support tools, automation solutions and monitoring devices, alongside Cleveland Clinic's vast clinical expertise and dedication to providing the highest quality, most innovative care, our partnership has the potential to significantly ease staff shortages, better standardize care, and promote intensivist- and specialist-led care," added Masimo Founder and CEO Joe Kiani. Mike Miliard is executive editor of Healthcare IT News Email the writer: mike.miliard@himssmedia.com Healthcare IT News is a HIMSS publication. The HIMSS AI in Healthcare Forum is scheduled to take place Sept. 5-6 in Boston. Learn more and register .
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。